Search

everythinglearnresearchcommunity

for

Search:↓

Human skin can make serotonin and melatonin.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Activating TLR3 may help produce retinoic acid, important for tissue regeneration.

Lower vitamin D levels are linked to higher CRP levels in people with a type of hair loss called alopecia areata.

The study suggests that mast cells might be involved in the hair loss condition telogen effluvium and could be a target for treatment.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Pressure-induced hair loss is rare, often reversible, and early diagnosis is crucial to prevent complications.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Low hemoglobin levels are significantly correlated with hair loss in women with Telogen Effluvium.

The document suggests using a topical Vitamin D treatment for hair loss rather than oral supplements and calls for more research.

The document concludes that a new treatment for a type of hair loss called telogen effluvium was tested and shows promise.

Rice husk and bran extracts from the Bue Bang 3 CMU variety can potentially treat hair loss due to their antioxidant, anti-inflammatory, and anti-androgenic properties.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

A specific pathway involving AR, miR-221, and IGF-1 plays a key role in causing common hair loss.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Cannabinoids may help treat various skin conditions.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Melanocyte stem cells are crucial for skin pigmentation and have potential in disease modeling and regenerative medicine.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

CRH in the skin acts like the body's stress response system, affecting cell behavior and immune activity.

Endocannabinoids help control mast cell activity in human skin.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Ficus carica leaf extract may help treat skin disorders by reducing inflammation and androgen effects in skin cells.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.